Tying our Fate to Molecular Markings
News Oct 16, 2012
In a new study, Emberly and his colleagues at Simon Fraser University cite proof that variable methylation, a chemical mark on our DNA, is predictive of age, gender, stress, cancer and early-life socioeconomic status within a population. The Proceedings of the National Academy of Sciences (PNAS) has just published the study online.
Working with researchers at the University of British Columbia and Stanford University, Eldon Emberly studied the variation of methylation over a large group of individuals.
DNA that is methylated in our genomes is known to affect whether genes are turned on or off. Gene expression predicates several attributes linked to our identity, such as gender, ethnicity, age and health.
The trio measured methylation from DNA in the white blood cells of 92 people aged 24 to 45. Emberly’s lab helped to mine the resulting data sets for correlations between variation in the chemical mark and variable social, psychological and physical traits in the subjects.
The results demonstrated that those who had experienced childhood poverty had a different methylation level from those who hadn’t. This was despite the fact everyone in the cohort had achieved the same socioeconomic status later in life.
That meant that early-life environment had left a detectable molecular mark on an individual’s DNA.
The correlation between methylation and gene expression was complex because it wasn’t always predictable but there was one connection of particular note says Emberly, an SFU associate professor.
“Variable methylation correlated with variable expression of the gene DDX4, which is linked to certain cancers.”
Emberly says this study’s discoveries raise interesting questions, as the connection between methylation and some traits, such as smoking and alcohol consumption, was weaker than expected or non existent.
“We’re now investigating whether methylation variation in different types of tissue is more predictive of some trait,” adds Emberly.
Pau Farre, a master’s of science student in physics under Emberly’s supervision, is doing a statistical analysis of the variability in methylation across tissues.
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.READ MORE
Scientists report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.